Laboratory control of heparin and heparin fragment treatment: an experimental study.
作者信息
Doutremepuich C, Lalanne M C, Guyot M, Doutremepuich F, De Sèze O, Toulemonde F
机构信息
Laboratorie d'hématologie, Faculté de Pharmacie, Bordeaux, France.
出版信息
Semin Thromb Hemost. 1989 Oct;15(4):373-7. doi: 10.1055/s-2007-1002733.
PMID:2554497
Abstract
摘要
相似文献
1
Laboratory control of heparin and heparin fragment treatment: an experimental study.
Semin Thromb Hemost. 1989 Oct;15(4):373-7. doi: 10.1055/s-2007-1002733.
2
Potentiation by heparin fragment CY 222 (Choay) of thrombolysis induced by human tissue-type plasminogen activator.
Semin Thromb Hemost. 1989 Oct;15(4):390-4. doi: 10.1055/s-2007-1002736.
3
Strategy for the development of the low molecular weight heparin fraction CY 216 in the prevention of postoperative deep vein thromboses in general surgery.
Semin Thromb Hemost. 1989 Oct;15(4):395-400. doi: 10.1055/s-2007-1002737.
4
Limitations of the laboratory monitoring of heparin therapy. Scientific and Standardization Committee Communications: on behalf of the Control of Anticoagulation Subcommittee of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis.肝素治疗实验室监测的局限性。科学与标准化委员会通讯：代表国际血栓与止血学会科学与标准化委员会抗凝控制小组委员会。
Thromb Haemost. 2002 Jan;87(1):163-4.
5
The contribution of anti-Xa and anti-IIa activities to the profibrinolytic activity of low-molecular-weight heparins.抗Xa和抗IIa活性对低分子量肝素纤溶活性的作用。
Thromb Haemost. 2009 Apr;101(4):782-5.
6
Low-molecular-weight heparin versus unfractionated heparin for unstable coronary disease.
N Engl J Med. 1998 Jan 8;338(2):130; author reply 131.
7
8
The effect of taurolidine on experimental thrombus formation.牛磺罗定对实验性血栓形成的影响。
Eur J Pharmacol. 2008 Jan 14;578(2-3):238-41. doi: 10.1016/j.ejphar.2007.08.035. Epub 2007 Sep 11.
9
A novel synthetic inhibitor of factor Xa decreases early reocclusion and improves 24-h patency after coronary fibrinolysis in dogs.一种新型凝血因子Xa合成抑制剂可降低犬冠状动脉纤溶后的早期再闭塞率，并改善24小时通畅率。
J Pharmacol Exp Ther. 2001 Feb;296(2):567-72.
10
Fibrinolytic and thrombolytic parameters in patients with deep vein thrombosis treated by low molecular weight and standard heparin.
Semin Thromb Hemost. 1989 Oct;15(4):435-9. doi: 10.1055/s-2007-1002743.
Zotero 插件